Date Speaker(s) Presentation Title
April 2017
Steven D. Pearson, M.D., M.Sc., F.R.C.P.

Steven D. Pearson, M.D., M.Sc., F.R.C.P.
Founder and President, Institute for Clinical Economic Review (ICER), Boston, MA

If Medicare Were to Negotiate Drug Prices, How Would it Determine a ‘Fair’ Price for a Cancer Treatment?
March 2017
 Angela Fagerlin, Ph.D.

Angela Fagerlin, Ph.D.
Professor & Chair, Department of Population Health Sciences, University of Utah

The Impact of Shared Decision-making Interventions on Prostate Cancer Treatment Decision-making
March 2017
Julie R. Palmer, Sc.D.

Julie R. Palmer, Sc.D.
Boston University

Type 2 Diabetes in Relation to Breast Cancer Risk: Results from the Black Women’s Health Study
March 2017
 Kate Sweeny, Ph.D.

Kate Sweeny, Ph.D.
University of California, Riverside Riverside, CA

The Psychological Impact of Awaiting Breast Diagnosis: A Preliminary Picture
February 2017
Betty Ferrell, Ph.D., M.A., F.A.A.N., F.P.C.N.

Betty Ferrell, Ph.D., M.A., F.A.A.N., F.P.C.N.
Beckman Research Institute of City of Hope

The Integration of Palliative Care into Standard Oncology Care
January 2017
Jim Evans, M.D., Ph.D.

Jim Evans, M.D., Ph.D.
The University of North Carolina at Chapel Hill

Cancer Prevention, Genomics, and the PMI
January 2017
Andrew Briggs, D.Phil., M.Sc.

Andrew Briggs, D.Phil., M.Sc.
University of Glasgow

Designing a value framework for oncology: what are the issues with existing frameworks and can we do better?
January 2017
Shiriki K. Kumanyika, Ph.D., M.P.H.

Shiriki K. Kumanyika, Ph.D., M.P.H.
University of Pennsylvania

Obesity, Cancer Prevention, and Health Equity. The Promise of Public Health Approaches
January 2017
Victoria L. Champion, Ph.D., R.N., F.A.A.N.

Victoria L. Champion, Ph.D., R.N., F.A.A.N.
Indiana University Simon Cancer Center

How do I develop a program of Cancer Control Science that will make a difference?
December 2016
Sudhir Srivastava, Ph.D., M.P.H., M.S.

Sudhir Srivastava, Ph.D., M.P.H., M.S.
NCI Division of Cancer Prevention

My Journey to Cancer Biomarker Research: Building a Translational Science Infrastructure - It Takes a Village
November 2016
Valerie M. Weaver, Ph.D.

Valerie M. Weaver, Ph.D.
University of California San Francisco

Force and Breast Cancer Risk
October 2016
Susan E. Olivo-Marston, Ph.D., M.P.H.

Susan E. Olivo-Marston, Ph.D., M.P.H.
The Ohio State University

Obesity and Colon Cancer…Does Timing Matter?”
October 2016
Erin Kent, Ph.D., M.S.

Erin Kent, Ph.D., M.S.
National Cancer Institute

Moving from Patient- to Family-Centric: Progress and Remaining Challenges in Cancer Caregiving
October 2016
Alan G. Nyitray, Ph.D.

Alan G. Nyitray, Ph.D.
National Cancer Institute

The Epidemiology of Anal HPV in High Risk Men and Novel Opportunities for Anal Cancer Screening
September 2016
Elizabeth A. Platz, Sc.D., M.P.H.

Elizabeth A. Platz, Sc.D., M.P.H.
John Hopkins Bloomberg School of Public Health

Enhancing the Infrastructure of a Cardiovascular Disease Cohort for Cancer Edpidemiology Research: Efforts, Findings, and Opportunities
June 2016
Douglas L. Weed, M.D., Ph.D., M.P.H.

Douglas L. Weed, M.D., Ph.D., M.P.H.
DLW Consulting Services, LLC

After the NCI: Methods, Mountains, and Mischief
May 2016
Sarah Gehlert, Ph.D.

Sarah Gehlert, Ph.D.
Washington University in St. Louis

The Effect of Social Influences on African-American Breast Cancer Patients
May 2016
Melinda L. Irwin, Ph.D., M.P.H.

Melinda L. Irwin, Ph.D., M.P.H.
Yale School of Medicine

Energy Balance Interventions: The New Adjuvant Therapy
May 2016
Nancy Krieger, Ph.D.

Nancy Krieger, Ph.D.
Boston University

Segregation, Jim Crow, Racism, Embodied History & the People’s Health: Implications for Cancer Registries, Research & Prevention
April 2016
Portrait of Rolando Herrero, M.D.

Rolando Herrero, M.D.
International Agency for Research on Cancer (IARC), Lyon, France

The IARC Research Program on Helicobacter Pylori and Gastric Neoplasia
April 2016
Ulrike Boehmer, Ph.D.

Ulrike Boehmer, Ph.D.
Boston University

Cancer and the LGBT Community: Reporting on an Understudied Population
April 2016
Sandro Galea, M.D., M.P.H., Dr.P.H.

Sandro Galea, M.D., M.P.H., Dr.P.H.
Boston University

The Principles of Population Health Science: Implications for Cancer Prevention
March 2016
Stephen Barnes, Ph.D.

Stephen Barnes, Ph.D.
University of Alabama at Birmingham

Understanding Diet Factors That Affect Cancer Risk
March 2016
Frank J. Penedo, Ph.D.

Frank J. Penedo, Ph.D.
Northwestern University

Enhancing Standards of Cancer Care by Capturing Patient Experiences in Academic and Community Settings
March 2016
Kurt M. Ribisl, Ph.D.

Kurt M. Ribisl, Ph.D.
UNCCH Gillings School of Global Public Health

Tobacco-related Disparities at Point of Sale and Promising Policy Solutions
February 2016
John F. McDonald, Ph.D.

John F. McDonald, Ph.D.
Georgia Institute of Technology

An Integrated Approach to Ovarian Cancer Diagnostics and Personalized Therapy
February 2016
Susan T. Mayne, Ph.D., F.A.C.E.

Susan T. Mayne, Ph.D., F.A.C.E.
Center for Food Safety and Applied Nutrition, FDA

FDA's Role in Translating Science for Improved Public Health/Cancer Prevention
January 2016
Melissa Troester, Ph.D., M.P.H.

Melissa Troester, Ph.D., M.P.H.
UNCCH Gillings School of Global Public Health

Landscape of Normal Breast and Breast Cancer
December 2015
Norma Fox Kanarek, Ph.D., M.P.H.

Norma Fox Kanarek, Ph.D., M.P.H.
Johns Hopkins School of Public Health

State Cancer Plans, Cancer Centers and Population Health: Tools or Toolbox?
December 2015
Corinne Husten, M.D., M.P.H.

Corinne Husten, M.D., M.P.H.
FDA

The FDA Center for Tobacco Products: Its Role in Reducing Tobacco Use and How Regulatory Science Informs Action